Correlation Between RYOHIN UNSPADR/1 and Moderna

Can any of the company-specific risk be diversified away by investing in both RYOHIN UNSPADR/1 and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RYOHIN UNSPADR/1 and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between RYOHIN UNSPADR1 and Moderna, you can compare the effects of market volatilities on RYOHIN UNSPADR/1 and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RYOHIN UNSPADR/1 with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of RYOHIN UNSPADR/1 and Moderna.

Diversification Opportunities for RYOHIN UNSPADR/1 and Moderna

-0.72

Correlation Coefficient

RYOHIN UNSPADR/1  Moderna

Pay attention - limited upside

The 3 months correlation between RYOHIN and Moderna is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding RYOHIN UNSPADR1 and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and RYOHIN UNSPADR/1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RYOHIN UNSPADR1 are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of RYOHIN UNSPADR/1 i.e., RYOHIN UNSPADR/1 and Moderna go up and down completely randomly.

Pair Corralation between RYOHIN UNSPADR/1 and Moderna

Assuming the 90 days trading horizon RYOHIN UNSPADR1 is expected to generate 0.37 times more return on investment than Moderna. However, RYOHIN UNSPADR1 is 2.72 times less risky than Moderna. It trades about 0.34 of its potential returns per unit of risk. Moderna is currently generating about -0.02 per unit of risk. If you would invest  1,800  in RYOHIN UNSPADR1 on October 22, 2024 and sell it today you would earn a total of  480.00  from holding RYOHIN UNSPADR1 or generate 26.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

RYOHIN UNSPADR1  vs.  Moderna

RYOHIN UNSPADR/1

Risk-Adjusted Performance

29 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in RYOHIN UNSPADR1 are ranked lower than 29 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain forward-looking signals, RYOHIN UNSPADR/1 reported solid returns over the last few months and may actually be approaching a breakup point.

Moderna

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with RYOHIN UNSPADR/1 and Moderna

The main advantage of trading using opposite RYOHIN UNSPADR/1 and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RYOHIN UNSPADR/1 position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.

The idea behind RYOHIN UNSPADR1 and Moderna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.